Plumas Bancorp PLBC
$60.96
-1.31%
at last close
Analyst Consensus
- Consensus Rating
- Buy (2 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $66.50
- Implied Upside
- +9.1%
- Price Target Range
- $64.00 – $69.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-16 | Piper SandlerMatthew Clark |
Maintains | Overweight | $66 → $69 |
| 2026-07-16 | Stephens & Co.Andrew Terrell |
Maintains | Overweight | $60 → $64 |
| 2026-04-16 | Piper SandlerMatthew Clark |
Maintains | Overweight | $59 → $63 |
| 2026-04-16 | Stephens & Co.Andrew Terrell |
Maintains | Overweight | $57 → $60 |
| 2026-04-02 | Piper SandlerMatthew Clark |
Maintains | Overweight | $61 → $59 |
| 2025-10-16 | Piper SandlerMatthew Clark |
Maintains | Overweight | $64 → $61 |
| 2025-07-17 | Piper SandlerMatthew Clark |
Maintains | Overweight | $65 → $64 |
| 2025-07-08 | Raymond JamesDaniel Tamayo |
Reiterates | Outperform | $48 → $50 |
| 2025-04-17 | Piper SandlerMatthew Clark |
Maintains | Overweight | $60 → $59 |
| 2025-02-27 | Piper SandlerMatthew Clark |
Initiates coverage on | Overweight | $60 |
| 2025-01-30 | Raymond JamesDavid Feaster |
Reiterates | Outperform | $49 → $54 |
| 2025-01-16 | Raymond JamesDavid Feaster |
Reiterates | Outperform | $45 → $49 |
| 2024-11-27 | Stephens & Co.Andrew Terrell |
Initiates coverage on | Overweight | $60 |
| 2024-10-02 | Raymond JamesDavid Feaster |
Maintains | Outperform | $43 → $45 |
| 2024-01-19 | Raymond JamesDavid Feaster |
Maintains | Outperform | $38 → $40 |
| 2023-08-31 | Raymond JamesDavid Feaster |
Initiates coverage on | Outperform | $38 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $60.96
- Market Cap
- $424.22 million
- 52-Week Range
- $39.80 – $64.00
- Average Volume
- 50K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
